Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication Stress

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cell Reports

Topics

Biology

Cancer Oncology

Pulmonary And Respiratory Medicine

Phenotype

Dna

Show all topics

DOI

10.1016/j.celrep.2020.107669

License

CC-BY-NC-ND

Other Formats

PDF